XML 38 R25.htm IDEA: XBRL DOCUMENT v3.5.0.2
Segment Reporting (Tables)
 6 Months Ended
Jun. 30, 2016
Segment Reporting [Abstract]  
Reconciliation of the Company's business segments to the consolidated financial statements
In millions
Pharmacy
Services
Segment(1)
 
Retail/LTC
Segment
 
Corporate
Segment
 
Intersegment
Eliminations(2)
 
Consolidated
Totals
Three Months Ended
 
 
 
 
 
 
 
 
 
June 30, 2016:
 
 
 
 
 
 
 
 
 
Net revenues
$
29,510

 
$
19,998

 
$
—

 
$
(5,783
)
 
$
43,725

Gross profit(3)
1,367

 
5,837

 
—

 
(189
)
 
7,015

Operating profit (loss)(3)
1,038

 
1,705

 
(220
)
 
(173
)
 
2,350

June 30, 2015:
 

 
 

 
 

 
 

 
 

Net revenues
24,442

 
17,242

 
—

 
(4,515
)
 
37,169

Gross profit
1,241

 
5,322

 
—

 
(161
)
 
6,402

Operating profit (loss)(4)
940

 
1,681

 
(215
)
 
(144
)
 
2,262

Six Months Ended
 

 
 

 
 

 
 

 
 

June 30, 2016:
 

 
 

 
 

 
 

 
 

Net revenues
58,275

 
40,110

 
—

 
(11,445
)
 
86,940

Gross profit(3)
2,469

 
11,667

 
—

 
(377
)
 
13,759

Operating profit (loss)(3)
1,820

 
3,482

 
(432
)
 
(344
)
 
4,526

June 30, 2015:
 

 
 

 
 

 
 

 
 

Net revenues
48,321

 
34,193

 
—

 
(9,013
)
 
73,501

Gross profit
2,267

 
10,617

 
—

 
(318
)
 
12,566

Operating profit (loss)(4)
1,675

 
3,408

 
(404
)
 
(285
)
 
4,394


(1) 
Net revenues of the Pharmacy Services Segment include approximately $2.6 billion and $2.2 billion of retail co-payments for the three months ended June 30, 2016 and 2015, respectively, as well as $5.6 billion and $4.7 billion of retail co-payments for the six months ended June 30, 2016 and 2015, respectively.
(2)
Intersegment eliminations relate to intersegment revenue generating activities that occur between the Pharmacy Services Segment and the Retail/LTC Segment. These occur in the following ways: when members of Pharmacy Services Segment clients (“members”) fill prescriptions at the Company's retail stores to purchase covered products, when members enrolled in programs such as Maintenance Choice ® elect to pick up maintenance prescriptions at one of the Company's retail stores instead of receiving them through the mail, or when members have prescriptions filled at the Company's long-term care pharmacies. When these occur, both the Pharmacy Services and Retail/LTC segments record the revenues, gross profit and operating profit on a standalone basis.
(3)
The Retail/LTC Segment gross profit and operating profit for the three months ended June 30, 2016 include $6 million and $81 million, respectively, of acquisition-related integration costs. The Retail/LTC Segment gross profit and operating profit for the six months ended June 30, 2016 include $10 million and $142 million, respectively, of acquisition-related integration costs. The integration costs are related to the acquisitions of Omnicare and the pharmacies and clinics of Target.
(4)
The Corporate Segment operating loss for the three and six months ended June 30, 2015 includes $21 million of acquisition-related transactions costs.